β-Lactamase inhibitors derived from single-domain antibody fragments elicited in the Camelidae

302Citations
Citations of this article
339Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Small, soluble single-domain fragments derived from the unique variable region of dromedary heavy-chain antibodies (VHHs) against enzymes are known to be potent inhibitors. The immunization of dromedaries with the TEM-1 and BcII β-lactamases has lead to the isolation of such single-domain antibody fragments specifically recognizing and inhibiting those β-lactamases. Two VHHs were isolated that inhibit TEM-1 and one BcII inhibiting VHH was identified. All inhibitory VHHs were tight-binding inhibitors. The 50% inhibitory concentrations were determined for all inhibitors and they were all in the same range as the enzyme concentration used in the assay. Addition of the VHHs to the TEM-1 β-lactamase, expressed on the surface of bacteria, leads to a higher ampicillin sensitivity of the bacteria. This innovative strategy could generate multiple potent inhibitors for all types of β-lactamases.

Cite

CITATION STYLE

APA

Conrath, K. E., Lauwereys, M., Galleni, M., Matagne, A., Frère, J. M., Kinne, J., … Muyldermans, S. (2001). β-Lactamase inhibitors derived from single-domain antibody fragments elicited in the Camelidae. Antimicrobial Agents and Chemotherapy, 45(10), 2807–2812. https://doi.org/10.1128/AAC.45.10.2807-2812.2001

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free